Shefferman Jesse
CEO and President
Shefferman Jesse has filed 4 SEC Form 4 filings (9 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Jul 1, 2026.
On the most recent filing, Shefferman Jesse is listed as CEO and President at Protara Therapeutics, Inc. Inside the rolling window, Shefferman Jesse reported no open-market purchases and 1 open-market sale totaling $882K in TARA.
Companies traded
Other insiders at TARA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$882K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Shefferman Jesse made?
Shefferman Jesse has filed 4 SEC Form 4 filings (9 transaction rows) across 1 company since 2026.
Which companies does Shefferman Jesse trade?
Shefferman Jesse has filed SEC Form 4 disclosures for 1 company, including TARA.
When was Shefferman Jesse's most recent SEC Form 4 filing?
Shefferman Jesse's most recent SEC Form 4 filing on Tracefour is dated Jul 1, 2026.
What is Shefferman Jesse's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Shefferman Jesse is listed as CEO and President.
What is Shefferman Jesse's total buy and sell value in the current window?
Inside the rolling retention window, Shefferman Jesse bought $0 and sold $882K based on SEC Form 4 filings.
What was Shefferman Jesse's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 215,687 TARA shares on 2026-06-29, worth $882K, per SEC Form 4 filings.